Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.
Key failure to deliver metrics for Quest Diagnostics
:
Last SEC data release: 2023-10-31
Last 15 days FTD volume: $0.14 M
Last 3 months FTD volume: $4.56 M
Last year FTD volume: $51.58 M
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations.
FTDs for US listed companies are reported to the SEC and published twice a month.
Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for Quest Diagnostics
(DGX) - 3 month history
Number of shares, 3 month chart
Biweekly Failures to deliver volume for Quest Diagnostics
(DGX) - since 2013
Volume in USD (price x number of shares), data since 2013
Quest Diagnostics
(DGX) Failure to deliver volume, Year over Year
Year
Volume (Price x Shares)
Change
2023
$48.56 M
74.35%
2022
$27.85 M
-61.47%
2021
$72.29 M
119.6%
2020
$32.92 M
-59.04%
2019
$80.37 M
47.27%
2018
$54.57 M
197.07%
2017
$18.37 M
-60.99%
2016
$47.09 M
14.17%
2015
$41.25 M
-56.86%
2014
$95.62 M
66.88%
2013
$57.3 M
FTD volume in the last 3 months for similar companies or competitors